New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps
Recursion official investor newsroom · Indexed industry source record · Source published: Mon Nov 02 2026 21:35:09 GMT+0000 (Coordinated Universal Time) · Indexed here: Mon Nov 02 2026 22:08:25 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps November 2, 2026 at 4:25 PM EST PDF Version Updated TUPELO results featured in a Presidential Plenary at CGA-IGC : Lisa Boardman , M.D., Professor of Medicine at Mayo Clinic , presented updated findings from the Phase 1b/2 TUPELO tria
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.